Therefore, combined therapies against the amyloid peptide and/or tau with immune system modulators and/or other alternatives such as apolipoprotein mimetic peptides [23,37,38], could constitute the solution for an effective AD treatment. This evidence concerns the gene MAPT and Alzheimer disease.